Is H. Lundbeck (CPH:HLUN B) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We note that H. Lundbeck A/S (CPH:HLUN B) does have debt on its balance sheet. But is this debt a concern to shareholders?

Advertisement

What Risk Does Debt Bring?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. If things get really bad, the lenders can take control of the business. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first step when considering a company's debt levels is to consider its cash and debt together.

Check out our latest analysis for H. Lundbeck

What Is H. Lundbeck's Net Debt?

As you can see below, H. Lundbeck had kr.3.72b of debt, at September 2024, which is about the same as the year before. You can click the chart for greater detail. However, it does have kr.8.32b in cash offsetting this, leading to net cash of kr.4.60b.

debt-equity-history-analysis
CPSE:HLUN B Debt to Equity History January 26th 2025

How Strong Is H. Lundbeck's Balance Sheet?

We can see from the most recent balance sheet that H. Lundbeck had liabilities of kr.7.78b falling due within a year, and liabilities of kr.7.91b due beyond that. Offsetting this, it had kr.8.32b in cash and kr.4.32b in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by kr.3.04b.

Since publicly traded H. Lundbeck shares are worth a total of kr.39.4b, it seems unlikely that this level of liabilities would be a major threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. While it does have liabilities worth noting, H. Lundbeck also has more cash than debt, so we're pretty confident it can manage its debt safely.

Fortunately, H. Lundbeck grew its EBIT by 3.1% in the last year, making that debt load look even more manageable. There's no doubt that we learn most about debt from the balance sheet. But it is future earnings, more than anything, that will determine H. Lundbeck's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

Finally, while the tax-man may adore accounting profits, lenders only accept cold hard cash. H. Lundbeck may have net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Happily for any shareholders, H. Lundbeck actually produced more free cash flow than EBIT over the last three years. That sort of strong cash generation warms our hearts like a puppy in a bumblebee suit.

Summing Up

We could understand if investors are concerned about H. Lundbeck's liabilities, but we can be reassured by the fact it has has net cash of kr.4.60b. The cherry on top was that in converted 109% of that EBIT to free cash flow, bringing in kr.4.9b. So we don't think H. Lundbeck's use of debt is risky. Another factor that would give us confidence in H. Lundbeck would be if insiders have been buying shares: if you're conscious of that signal too, you can find out instantly by clicking this link.

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

Valuation is complex, but we're here to simplify it.

Discover if H. Lundbeck might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About CPSE:HLUN B

H. Lundbeck

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Undervalued with solid track record.

Advertisement

Weekly Picks

JO
Jolt_Communications
MYSE logo
Jolt_Communications on Myseum ·

The Future of Social Sharing Is Private and People Are Ready

Fair Value:US$7.9577.4% undervalued
35 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TO
Tokyo
ASML logo
Tokyo on ASML Holding ·

EU#3 - From Philips Management Buyout to Europe’s Biggest Company

Fair Value:€1.31k9.0% undervalued
30 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
YI
BKNG logo
yiannisz on Booking Holdings ·

Booking Holdings: Why Ground-Level Travel Trends Still Favor the Platform Giants

Fair Value:US$5.47k6.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
CO
composite32
SHEL logo
composite32 on Shell ·

A fully integrated LNG business seems to be ignored by the market.

Fair Value:UK£36.122.7% undervalued
38 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

CO
composite32
SGRO logo
composite32 on SEGRO ·

SEGRO's Revenue to Rise 14.7% Amidst Optimistic Growth Plans

Fair Value:UK£9.3918.8% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AL
alex30free
BEIJ B logo
alex30free on Beijer Ref ·

The Green Consolidator

Fair Value:SEK 128.821.0% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
EDP logo
BenjaminMartins on EDP ·

EDP as a safe capital allocation with a potential upside of 28% with steady dividends

Fair Value:€513.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8236.2% undervalued
85 users have followed this narrative
6 users have commented on this narrative
35 users have liked this narrative
OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3324.6% undervalued
75 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.6% undervalued
1049 users have followed this narrative
6 users have commented on this narrative
31 users have liked this narrative

Trending Discussion

HE
Hemingway
AEVA logo
Hemingway on Aeva Technologies ·

NVDA+AEVA Agreement is a game changer for the AEVA stock even though it is just a partnership and does not have a roll out until 2028 (which means receivables as early as 2027, I would imagine) This agreement effectively moves the goal posts of profitability for AEVA much closer since this is in addition to the recent Forterra agreement, as well as the (previously announced) European carmaker agreement (which is believed to be Mercedes-Benz and estimated to be worth at least 1 billion in sales alone) Underneath all of this, AEVA has a pre-existing agreement with Daimler Truck. So business seems to be booming, especially with really big name brands…which tends to bring in even more brand names (and thus more agreements/contracts/announcements, etc). This dynamic often creates more coverage from analysts (often with upside stock initial coverage) that I believe will be occurring over the next 3 to 6 months (as professional traders/analysts often research for 2 to 3 months before initiating coverage of a new issue). I also feel that the above momentum increases the likelihood that companies that do not currently utilize 4G LIDAR technology might consider buying AEVA outright. Realistically, even with a substantial premium to the current stock price, the cost of AEVA would be a rounding error for the likes of a company such as Tesla, and certainly would allow them to maintain their technological edge as the competition for self-driving vehicles continues to heat up. However, I think it is equally possible for NVidea to decide to lock-in the AEVA technology for their upcoming autonomous hardware/software package by buying them outright. Obviously, the above factors and recent activity in the AEVA stock are cause for optimism. Of course, this all just one opinion , so please do your own due diligence. Disclaimer: I/We DO trade in this stock from time to time and I/we may (or may not have) a position currently, so again, please do your own due diligence.

0
|
0
US
AVGO logo
User on Broadcom ·

Net here,remains to be seen!

0
|
0
Advertisement